Phytochemical and biological analysis of skullcap (Scutellaria lateriflora L.): a medicinal plant with anxiolytic properties
Awad R, Arnason JT, Trudeau V, Bergeron C, Budzinski JW, Foster BC, Merali Z
Published in Canadian Journal of Physiology and Pharmacology
Methodology
Laboratory characterisation of skullcap flavonoids with GABA-A receptor binding assays and behavioural testing.
Key Findings
Skullcap extracts contained baicalin and baicalein and displaced ligands at GABA-A receptors, consistent with anxiolytic activity.
Conclusions
Constituents of S. lateriflora provide a plausible GABAergic mechanism for reported calming effects.
Limitations
Preclinical and in vitro; does not establish clinical efficacy or dosing.
Supplements Studied
Constituents of S. lateriflora provide a plausible GABAergic mechanism for reported calming effects.
Outcomes Measured
Skullcap extracts displaced ligands at GABA-A receptors, consistent with anxiolytic activity.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.